Greater China: Headline - J&J awards Tylenol China business to Euro RSCG

Johnson & Johnson Tylenol has appointed Euro RSCG to handle its business in China. The win covers Tylenol, the new Tynox lozenges and other new products. Incumbent Saatchi & Saatchi did not repitch. R3 is understood to have assessed McCann Healthcare, JWT and Euro RSCG, as well as pay-for-performance compensation terms.

Please sign in below or access limited articles a month after free, fast registration.

 If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.

Register for free

✓ Access limited free articles each month

✓ Email bulletins – top industry news and insights delivered straight to your inbox

Register now

Subscribe

✓ Unlimited access to all Campaign Asia content

✓ Real-world campaign case studies and career insights

✓ Exclusive reports, industry news, and annual features

Join now